For the hundreds of thousands of Americans left adrift after Lyme disease treatment — still exhausted, still foggy, still in pain — conventional medicine has offered little more than uncertainty. A small but carefully conducted pilot study at Johns Hopkins now suggests that psilocybin, administered under clinical supervision, may quiet those lingering symptoms in ways antibiotics cannot. The findings are preliminary, the researchers are the first to say so, and yet they arrive at a moment when patients and scientists alike are asking whether the tools of consciousness might reach where the too
Johns Hopkins pilot study shows psilocybin may ease persistent Lyme disease symptoms
Hundreds of thousands of Americans suffer from persistent post-treatment Lyme disease symptoms including fatigue, cognitive dysfunction, and pain that significantly impact quality of life.